Matthew J. Budoff MD, FACC, FAHAProfessor of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California; Endowed Chair of Preventive Cardiology, Lundquist Institute, Harbor-UCLA Medical Center, Torrance, California
Matthew Jay Budoff, MD, FACC, FAHA, is a professor of medicine at David Geffen School of Medicine at UCLA and the Endowed Chair of Preventive Cardiology at Harbor-UCLA Medical Center. Dr. Budoff is a graduate of University of California at Riverside (BS) and graduated a member of Alpha Omega Alpha from George Washington University School of Medicine (MD). He completed his training in internal medicine and his cardiology fellowship at Harbor-UCLA Medical Center. Dr. Budoff is on the editorial boards of several cardiology journals, including Clinical Cardiology, Journal of Invasive Cardiology, JACC: Cardiovascular Imaging, and Cardiovascular Diabetology. Dr. Budoff has served on a number of association committees, including member of the ACC Annual Scientific Session program committee (2013–2015). He also serves on the executive committee of the ACC Center of Excellence on Cardiovascular Risk Reduction (2018-2020).
Dr. Budoff has author or coauthored more than 50 books and book chapters and more than 2000 articles and abstracts. He has received numerous research grants from the National Institutes of Health and has been invited to lecture at cardiology conferences around the world. In addition to his 2015 appointment as the Endowed Chair of Preventive Cardiology at Harbor-UCLA Medical Center, he has been recognized for his work by the Society of Cardiovascular Computed Tomography, from which he received the Gold Medal Award and recently designated as Master of the Society of Cardiovascular Computed Tomography (MSCCT), and has been inducted into the European Academy of Sciences. Dr. Budoff has been named to “America’s Top Doctors” for each of the past 9 years. In 2011, he was named a US News Top Doctor for cardiology, was awarded the Albert Nelson Marquis Lifetime Achievement Award in 2018 and named to “The world’s most influential scientific researchers” in 2018 and 2019.
Recent Contributions to PracticeUpdate:
- Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients With Familial Hypercholesterolemia
- CAC Score Predicts Lifetime CVD Risk in Patients With and Without Diabetes
- High-Risk Coronary Plaque Regression After Intensive Lifestyle Intervention in Nonbstructive Coronary Disease
- Earlier Increase in Coronary Artery Calcium in Individuals With Type 2 Diabetes
- Pericardial Fat and the Risk of Heart Failure
- Asymptomatic Left Ventricular Dysfunction in Type 2 Diabetics Without Known Cardiovascular Disease
- Nonculprit Lesion Plaque Morphology in Patients With STEMI
- Short-Term Progression of Multiterritorial Subclinical Atherosclerosis
- Plaque Morphology as Predictor of Late Plaque Events in Patients With Asymptomatic Type 2 Diabetes
- MY APPROACH to Interpreting Changes in Coronary Plaque Volume